140 related articles for article (PubMed ID: 34056907)
41. Metabolic and lipidomic characterization of malignant pleural effusion in human lung cancer.
Yang Z; Song Z; Chen Z; Guo Z; Jin H; Ding C; Hong Y; Cai Z
J Pharm Biomed Anal; 2020 Feb; 180():113069. PubMed ID: 31884394
[TBL] [Abstract][Full Text] [Related]
42. NMR and LC/MS-based global metabolomics to identify serum biomarkers differentiating hepatocellular carcinoma from liver cirrhosis.
Liu Y; Hong Z; Tan G; Dong X; Yang G; Zhao L; Chen X; Zhu Z; Lou Z; Qian B; Zhang G; Chai Y
Int J Cancer; 2014 Aug; 135(3):658-68. PubMed ID: 24382646
[TBL] [Abstract][Full Text] [Related]
43. Identification and Validation of Plasma Metabolomics Reveal Potential Biomarkers for Coronary Heart Disease.
Fu H; Zhu K; Zhou D; Guan Y; Li W; Xu S
Int Heart J; 2019 Nov; 60(6):1387-1397. PubMed ID: 31666452
[TBL] [Abstract][Full Text] [Related]
44. Untargeted LC-HRMS-based metabolomics to identify novel biomarkers of metastatic colorectal cancer.
Martín-Blázquez A; Díaz C; González-Flores E; Franco-Rivas D; Jiménez-Luna C; Melguizo C; Prados J; Genilloud O; Vicente F; Caba O; Pérez Del Palacio J
Sci Rep; 2019 Dec; 9(1):20198. PubMed ID: 31882610
[TBL] [Abstract][Full Text] [Related]
45. CMap analysis identifies Atractyloside as a potential drug candidate for type 2 diabetes based on integration of metabolomics and transcriptomics.
Li H; Shi X; Jiang H; Kang J; Yu M; Li Q; Yu K; Chen Z; Pan H; Chen W
J Cell Mol Med; 2020 Jul; 24(13):7417-7426. PubMed ID: 32469143
[TBL] [Abstract][Full Text] [Related]
46. Study of the metabolomic relationship between lung cancer and chronic obstructive pulmonary disease based on direct infusion mass spectrometry.
Callejón-Leblic B; Pereira-Vega A; Vázquez-Gandullo E; Sánchez-Ramos JL; Gómez-Ariza JL; García-Barrera T
Biochimie; 2019 Feb; 157():111-122. PubMed ID: 30439409
[TBL] [Abstract][Full Text] [Related]
47. SWATHtoMRM: Development of High-Coverage Targeted Metabolomics Method Using SWATH Technology for Biomarker Discovery.
Zha H; Cai Y; Yin Y; Wang Z; Li K; Zhu ZJ
Anal Chem; 2018 Mar; 90(6):4062-4070. PubMed ID: 29485856
[TBL] [Abstract][Full Text] [Related]
48. Metabolomics strategy assisted by transcriptomics analysis to identify biomarkers associated with schizophrenia.
Liu L; Zhao J; Chen Y; Feng R
Anal Chim Acta; 2020 Dec; 1140():18-29. PubMed ID: 33218480
[TBL] [Abstract][Full Text] [Related]
49. Metabolomic-based biomarker discovery for non-invasive lung cancer screening: A case study.
O'Shea K; Cameron SJ; Lewis KE; Lu C; Mur LA
Biochim Biophys Acta; 2016 Nov; 1860(11 Pt B):2682-7. PubMed ID: 27423423
[TBL] [Abstract][Full Text] [Related]
50. Monitoring tyrosine kinase inhibitor therapeutic responses with a panel of metabolic biomarkers in chronic myeloid leukemia patients.
Yang B; Wang C; Xie Y; Xu L; Wu X; Wu D
Cancer Sci; 2018 Mar; 109(3):777-784. PubMed ID: 29316075
[TBL] [Abstract][Full Text] [Related]
51. An integrated pathological research for precise diagnosis of schizophrenia combining LC-MS/
Wang T; Li P; Meng X; Zhang J; Liu Q; Jia C; Meng N; Zhu K; Lv D; Sun L; Shang T; Lin Y; Niu W; Lin S
Clin Chim Acta; 2022 Jan; 524():84-95. PubMed ID: 34863699
[TBL] [Abstract][Full Text] [Related]
52. Untargeted mass spectrometry-based metabolomic profiling of pleural effusions: fatty acids as novel cancer biomarkers for malignant pleural effusions.
Lam CW; Law CY
J Proteome Res; 2014 Sep; 13(9):4040-6. PubMed ID: 25117182
[TBL] [Abstract][Full Text] [Related]
53. Novel serum metabolomics-based approach by gas chromatography/triple quadrupole mass spectrometry for detection of human skin cancers: Candidate biomarkers.
Fukumoto T; Nishiumi S; Fujiwara S; Yoshida M; Nishigori C
J Dermatol; 2017 Nov; 44(11):1268-1275. PubMed ID: 28593747
[TBL] [Abstract][Full Text] [Related]
54. An NMR metabolomics approach for the diagnosis of leptomeningeal carcinomatosis in lung adenocarcinoma cancer patients.
An YJ; Cho HR; Kim TM; Keam B; Kim JW; Wen H; Park CK; Lee SH; Im SA; Kim JE; Choi SH; Park S
Int J Cancer; 2015 Jan; 136(1):162-71. PubMed ID: 24798643
[TBL] [Abstract][Full Text] [Related]
55. Rapid Prostate Cancer Noninvasive Biomarker Screening Using Segmented Flow Mass Spectrometry-Based Untargeted Metabolomics.
Pinto FG; Mahmud I; Harmon TA; Rubio VY; Garrett TJ
J Proteome Res; 2020 May; 19(5):2080-2091. PubMed ID: 32216312
[TBL] [Abstract][Full Text] [Related]
56. A novel analysis method for biomarker identification based on horizontal relationship: identifying potential biomarkers from large-scale hepatocellular carcinoma metabolomics data.
Su B; Luo P; Yang Z; Yu P; Li Z; Yin P; Zhou L; Fan J; Huang X; Lin X; Qiao Y; Xu G
Anal Bioanal Chem; 2019 Sep; 411(24):6377-6386. PubMed ID: 31384984
[TBL] [Abstract][Full Text] [Related]
57. Identification of FUT7 hypomethylation as the blood biomarker in the prediction of early-stage lung cancer.
Qiao R; Di F; Wang J; Wei Y; Xu T; Dai L; Gu W; Han B; Yang R
J Genet Genomics; 2023 Aug; 50(8):573-581. PubMed ID: 36898609
[TBL] [Abstract][Full Text] [Related]
58. Circulating Tumor Cell and Metabolites as Novel Biomarkers for Early-Stage Lung Cancer Diagnosis.
Wan L; Liu Q; Liang D; Guo Y; Liu G; Ren J; He Y; Shan B
Front Oncol; 2021; 11():630672. PubMed ID: 34136379
[TBL] [Abstract][Full Text] [Related]
59. Exploring metabolic alterations associated with death from asphyxia and the differentiation of asphyxia from sudden cardiac death by GC-HRMS-based untargeted metabolomics.
Zhang K; Yan H; Liu R; Xiang P; Deng K; Zhang J; Tuo Y; Wang Z; Huang P
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 May; 1171():122638. PubMed ID: 33744599
[TBL] [Abstract][Full Text] [Related]
60. Serum-plasma matched metabolomics for comprehensive characterization of benign thyroid nodule and papillary thyroid carcinoma.
Huang FQ; Li J; Jiang L; Wang FX; Alolga RN; Wang MJ; Min WJ; Ma G; Zhao YJ; Wang SL; Yu Y; Chen X; Zhu D; Zhu J; Wang G; Xia T; Sang JF; Lai MD; Li P; Zhu W; Qi LW
Int J Cancer; 2019 Feb; 144(4):868-876. PubMed ID: 30318614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
